Home › Calculator › NRSNW Dividend Calculator 2026
NRSNW Dividend DRIP Calculator 2026
1684.92% YieldHealthcareNeuroSense Therapeutics Ltd. · NASDAQ
Price: $0.12 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NRSNW pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NRSNW snowball 📈
$10,000 in NRSNW → $32823695593.99M in 10 years · $2,582,062,553,609,408.00/month
About NeuroSense Therapeutics Ltd. (NRSNW) — Dividend Analysis 2026
NeuroSense Therapeutics Ltd. is an Israeli clinical-stage biotechnology firm dedicated to pioneering novel therapies for severe neurodegenerative conditions. Its most advanced investigational asset is PrimeC, an innovative oral compound specifically engineered to address amyotrophic lateral sclerosis (ALS). Beyond its lead program, the company boasts a preclinical pipeline featuring StabiliC, aimed at Parkinson's disease, and CogniC, targeting Alzheimer's disease. Established in Herzliya, Israel, in 2017, NeuroSense Therapeutics continues to advance its therapeutic initiatives.
Compare NRSNW with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NRSNW DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NRSNW position with:
🌍 NRSNW Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NRSNW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1684.92% | 1682.12% | $168,492 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 1432.18% | 1429.38% | $143,218 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 1347.94% | 1345.14% | $134,794 / yr |
| 🇬🇧 UK ISA | 0% | 1684.92% | 1682.12% | $168,492 / yr |
| 🇬🇧 UK Taxable | 8.75% | 1537.49% | 1534.69% | $153,749 / yr |
| 🇨🇦 TFSA | 0% | 1684.92% | 1682.12% | $168,492 / yr |
| 🇨🇦 CA Taxable | 25% | 1263.69% | 1260.89% | $126,369 / yr |
| 🇦🇺 Super (pension) | 15% | 1432.18% | 1429.38% | $143,218 / yr |
| 🇦🇺 AU Taxable | 30% | 1179.44% | 1176.64% | $117,944 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1240.52% | 1237.72% | $124,052 / yr |
| 🇫🇷 FR Taxable | 30% | 1179.44% | 1176.64% | $117,944 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NRSNW Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NRSNW Dividend Payment Schedule
NRSNW pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NRSNW vs Healthcare Benchmarks
How NRSNW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NRSNW sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NRSNW Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-06-16 | 250,000 | $0.80 | $200.0K | ||
| Buy | 2026-06-16 | 250,000 | $0.80 | $200.0K | ||
| A-Award | 2026-03-26 | 200,000 | — | — | ||
| Other | 2021-07-01 | 21,000 | $0.03 | $693.00 | ||
| Other | 2024-08-15 | 66,666 | $0.75 | $50.0K | ||
| Other | 2023-03-10 | 72,000 | $1.43 | $103.0K | ||
| A-Award | 2026-03-26 | 200,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-06-16
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NRSNW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
NeuroSense Therapeutics Ltd. (NRSNW) is currently trading at $0.12, 88% below its 52-week high. The current dividend yield is 1684.92% based on an annual payout of $2.00 per share.
NRSNW (NeuroSense Therapeutics Ltd.) — 1684.92% Dividend Yield Analysis
NeuroSense Therapeutics Ltd. (NRSNW) is a healthcare stock currently trading at $0.12 with a dividend yield of 1684.92%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (1684.92%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest NRSNW News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.